Starlab developer Voyager seeks $1.6 billion valuation in US IPO
Voyager Technologies said on Monday it was targeting a valuation of $1.6 billion in its U.S. listing, as the defense and space tech company looks to capitalize on a spending boost for the sector under the Trump administration.
Companies are finding renewed opportunities to list shares on U.S. exchanges after the IPO market recovery was delayed by policy uncertainties linked to President Donald Trump's trade policies.
Voyager's filing comes after digital banking startup Chime and stablecoin giant Circle also reignited their plans to go public in recent weeks.
The Denver, Colorado–based company plans to sell 11 million shares and would raise $319 million if priced at the top of its proposed $26 to $29 range.
The U.S. government is expected to boost spending on defense and space projects, with policymakers predicting Trump would push ahead with a race to the moon and possibly Mars, bolstered by his friendship with SpaceX founder Elon Musk.
Last month, Trump selected a design for his $175 billion Golden dome missile defense shield, which aims to create a network of satellites to detect, track and potentially intercept incoming missiles.
Founded in 2019, Voyager has completed more than 2,000 missions from about 35 nations, according to its website.
The company is also developing Starlab, a potential commercial successor to the International Space Station, via a joint venture with Airbus, Mitsubishi, and Palantir.
The company reported $34.5 million in net sales for the quarter ended March 31, up 14.2 per cent from the previous year. Losses attributable to Voyager, however, nearly doubled to $26.9 million in the period.
Voyager's shares will trade on the New York Stock Exchange under the symbol "VOYG".
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CNA
29 minutes ago
- CNA
J-pop star Ayumi Hamasaki denies Elon Musk fathered her children, following rumours
J-pop star Ayumi Hamasaki has shut down rumours that she had a child with Elon Musk. The rumours started when, during an interview with American newspaper The New York Times in late May, author Ashley St Claire said that Musk was the father of the child of 'a Japanese pop star'. St Claire announced on X in February that she and the Tesla CEO share a son. Musk has 14 known children. Hamasaki, who has two young children, spoke up against the rumours on Monday (Jun 2) on Instagram, denying the viral speculations. The 46-year-old star said in Japanese: 'I've been keeping an eye on this, and I guess it's time for me to speak up. Elon Musk is not the father of [either of] my children.' She added: 'I mean, I can understand if someone were to think it seems like the sort of thing I'd do. Even my mum laughed when she heard the rumours, saying, 'This seems kind of Ayu-like,' and if I were someone else, I'd probably be saying 'Ayu is the pop star [St Claire] was talking about, right?'' However, she added, the rumours that Musk fathered one of her kids is "just not true'. Hamasaki was previously married to Austrian actor-model Manuel Schwarz from 2011 to 2012, and to American medical student Tyson Bodkin from 2014 to 2016. She also had a seven-year relationship with actor-singer Tomoya Nagase, which ended in 2007. 'Setting aside my personal image, when my kids are old enough to start googling things, I don't want them to run into the rumours and think they're true, so I'm firmly denying them," Hamasaki said. Hamasaki, best known for her songs Seasons (2000) and Blue Bird (2006), debuted in 1998 with her album A Song For XX and recently released her newest single Mimosa on Apr 8, commemorating her 27th anniversary. She is also the first female solo artiste in Japan to have 25 consecutive No 1 singles. In 2008, Hamasaki revealed that she had gone deaf in her left ear due to an ear infection she had caught in the middle of her tour in 2000. By 2017, she also began experiencing hearing loss in her right ear.
Straits Times
34 minutes ago
- Straits Times
China really wants to attract talented scientists, Trump just helped
Last week, the Trump administration said it would work to 'aggressively revoke' the visas of Chinese students in 'critical fields'. PHOTO: AFP China really wants to attract talented scientists, Trump just helped HANGZHOU – China was already scoring wins in its rivalry with the United States for scientific talent. It had drawn some of the world's best researchers to its campuses, people decorated with Nobel Prizes, MacArthur 'Genius' grants and seemingly every other academic laurel on offer. Now the Trump administration's policies might soon bolster China's efforts. Under President Donald Trump, the United States is slashing the research funding that helped establish its reputation as the global leader in science and technology. The president is also attacking the country's premier universities, and trying to limit the enrollment of international students. Scientists from China are under particular pressure, as US officials have said that they may pose a national security threat by funneling valuable knowledge to China. Chinese-born scientists have been investigated or even arrested. Last week, the Trump administration said it would work to 'aggressively revoke' the visas of Chinese students in 'critical fields'. As a result, many scholars are looking elsewhere. And Chinese institutions have been quick to try to capitalise. Universities in Hong Kong and Xi'an said they would offer streamlined admission to transfer students from Harvard University. An ad from a group with links to the Chinese Academy of Sciences welcomed 'talents who have been dismissed by the US NIH,' or National Institutes of Health. 'The United States is shooting itself in the foot,' said anatomy expert Zhang Xiaoming, who in 2024 left the Baylor College of Medicine, in Texas, to lead the medical education program at Westlake University, a research university in the tech hub of Hangzhou. 'Since I went to the United States more than 30 years ago, so much of its research has been supported by foreigners, including many Chinese,' said Dr Zhang, who emphasised that he was speaking for himself, not his employer. 'Without foreigners, at least in the field of scientific research, they can't go on.' On its own, China had become more attractive to scientists in recent years because of the huge investments the country has made in research. Westlake is a prime example. Established in 2018 by several high-profile scientists who had returned to China from the West, Westlake's campus exudes technological advancement. A spaceshiplike tower looms over rows of research laboratories. Computing centers and animal testing facilities cluster around a central lawn, in a shape designed to evoke a biological cell. In its main academic building, portraits of dozens of professors are on display – all of whom were recruited from overseas. There is Dr Guan Kunliang, a biochemist who won a MacArthur 'Genius' grant while in Michigan; Dr Cheng Jianjun, a materials engineer honored multiple times by the National Science Foundation; Dr Yu Hongtao, a Harvard-educated cell biologist who received millions in funding from the Howard Hughes Medical Institute in Maryland. Recruitment notices advertise high compensation, in line with those at top foreign universities. Westlake has been perhaps the most successful Chinese university at recruiting overseas talent, but it is far from the only one. Between 2010 and 2021, nearly 12,500 scientists of Chinese descent left the United States for China, according to a study published in Proceedings of the National Academy of Sciences. The rate of departure was accelerating: More than half of them left in just the five years between 2017 and 2021. The trend has only continued in the past few years, said Professor Yu Xie from Princeton University who co-authored the study. Nor is it only Chinese-born scientists who are jumping ship. Former Harvard chemist Charles Lieber, who was convicted in 2023 of failing to disclose payments from a Chinese university, recently joined Tsinghua University. Chinese scientists have long flocked to American universities, lured by the promise of a world-class education and resources that their home country could not provide. In the 1980s, Chinese scientists who visited the United States would collect disposable test tubes to reuse in China, said neurobiologist Rao Yi at Peking University in Beijing, who studied and worked in the United States for two decades. The admiration continued even as China's economy boomed. In 2020, nearly one-fifth of doctorates in science, technology, engineering and mathematics awarded in the United States went to students from China, according to data from the National Science Foundation. Historically, the vast majority of those doctorates stayed in the United States – 87 per cent between 2005 and 2015, the data showed. Many became US citizens, and they have helped the United States accumulate patents, publications and Nobel Prizes. In recent years, more scientists have been returning to China, drawn partly by government recruitment programs promising them millions of dollars in funding as well as housing subsidies and other perks. China's spending on research and development is now second only to the United States. And Chinese institutions such as Tsinghua and Zhejiang University now routinely rank among the best in the world for science and technology. The investment is part of a plan to turn China into a scientific superpower, especially in strategically important fields such as artificial intelligence, semiconductors and biotechnology. 'The scientific and technological revolution is intertwined with the game between superpowers,' China's leader Xi Jinping said in 2024. At the same time, the United States has been pushing scientists away for years, in particular by investigating their ties with China. Protein chemist Lu Wuyuan, formerly at the University of Maryland, was one of those targeted. He was investigated by the National Institutes of Health for allegedly failing to disclose research ties to China – ties he said Maryland knew about. After 20 years at the university, he quit in 2020. Most of the cases brought under the so-called China Initiative eventually collapsed. Many researchers criticised the campaign as racial profiling. Dr Lu, who now works at Fudan University in Shanghai, said that many of his friends mused about leaving the United States, but most chose to stay because they had settled there. The Trump administration's assault on research funding may change that. 'If they cut so much funding, I believe that may be the last straw for many people,' Dr Lu said. Still, China faces its own issues in poaching talent. It has become harder for Chinese universities to meet and woo overseas scientists, as Chinese scholars have had trouble securing visas to the United States to attend academic conferences. Researchers in America also face restrictions in visiting China; Texas, for example, prohibits employees of public universities from traveling to China for work. The scientists who have returned to China largely fall into a few categories: those who are early in their careers, or who are nearing retirement, or who felt pushed out by investigations. Established midcareer scholars are still reluctant to leave, multiple scientists said. Dr Rao at Peking University, who was also one of Westlake's co-founders, said that China's progress in recruiting international talent had also been hampered by cronyism and jealousy among domestic colleagues. 'While funding should increase, it is not the key factor at this stage,' Dr Rao said. 'Supporting scientists based on merit and their good science is the key.' Even at home, scientists are not spared political scrutiny. Chinese universities face limits on free expression, and China's Ministry of State Security has warned that scholars returning from overseas may be spies. Multiple Chinese-born scientists – both those who had returned to China, and those still in the United States – emphasised that they did not want to get entangled in politics. They were just trying to do good work. The simple fact was, many agreed, that it was increasingly easier to do so in China. 'It's hard to survive in America. And China is developing so fast,' said artificial intelligence researcher Fu Tianfan, 32, who left Rensselaer Polytechnic Institute in December 2024 to join Nanjing University. 'Whether it was the best choice,' he said, 'it may take some time to say.' NYTIMES Join ST's Telegram channel and get the latest breaking news delivered to you.
Business Times
an hour ago
- Business Times
Asia: Stocks track Wall Street up after jobs data, Seoul surges on Lee win
[HONG KONG] Asian shares extended a global rise on Wednesday following data indicating the US economy remained resilient, with South Korean equities and the won standing out as the election of a new president ended months of political paralysis. Speculation that US President Donald Trump and Chinese leader Xi Jinping will speak this week stoked optimism for a soothing of trade tensions between Washington and Beijing. However, Trump's ramped-up tariffs on aluminium and steel imports - announced on Friday - are due to kick in later Wednesday, highlighting the uncertainty caused by the White House's off-the-cuff policies. Traders in Asia took the baton from a positive Wall Street, where all three main indexes were lifted by data showing US job openings unexpectedly rose in April, calming worries about the impact of Trump's tariff blitz on the world's number one economy. The reading came ahead of crucial non-farm payrolls figures on Friday, which are closely followed by the US Federal Reserve as it maps monetary policy in light of weak growth and fears of tariff-fuelled inflation. 'Growth is sputtering, the second half looks increasingly cloudy, and everyone knows the Fed's rate-cut cavalry will ride in eventually. It's already priced, already scripted - no one's shocked by the plot twist unless, of course, inflation proves stickier than expected,' said Stephen Innes at SPI Asset Management. BT in your inbox Start and end each day with the latest news stories and analyses delivered straight to your inbox. Sign Up Sign Up 'But what's genuinely keeping equities ticking higher is the soft hum of hope - that US-China tensions could thaw into something warmer than their current frosty detente,' Innes said. He added that the risk of tariffs, 'once a terrifying monster, now looks more like a toothless terrier's wag, comforting investors enough to hold their ground despite the global economy's chills'. Traders are awaiting further developments on the China-US front after White House officials said the two nations' leaders could talk this week, even after Trump accused Beijing of violating last month's detente that slashed tit-for-tat tariffs. News that eurozone inflation had eased in May to its lowest level in eight months - and slipped back below the European Central Bank's two-per cent target - added to the upbeat mood. Tokyo, Hong Kong, Shanghai, Sydney, Wellington, Taipei, Manila and Jakarta all rose. Seoul rallied more than two per cent - pushing into a bull market after rising more than 20 percent from its recent low - as Lee Jae Myung won South Korea's snap presidential election. The won gained around 0.3 per cent. The poll was called after the impeachment of predecessor Yoon Suk Yeol over his brief martial law attempt and ended six months of political turmoil in the country. It has also raised hopes that Lee will introduce fresh measures to boost the export-dependent economy, which faces a hefty hit from Trump's tariffs, particularly the huge levies on steel and aluminium. In his inauguration speech on Wednesday, the new president warned protectionism posed a threat to the country's 'survival'. On the campaign trail, Lee said Seoul needed to start tariff negotiations with Washington 'immediately' but also stressed there was no need to 'rush' a deal. AFP
